RONALD PATTERSON: Open Payments
NPI 1376159400 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,130 in 116 payments from 19 companies in 2025. Trend: 2023 $13,148 · 2024 $2,510 · 2025 $2,130
Food & beverage: $2,130
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $429 |
| Otsuka America Pharmaceutical, Inc. | 17 | $286 |
| Vanda Pharmaceuticals Inc. | 12 | $276 |
| Alkermes, Inc. | 11 | $180 |
| Collegium Pharmaceutical, Inc. | 10 | $171 |
| Axsome Therapeutics, Inc. | 10 | $145 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $121 |
| Tris Pharma Inc | 5 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $89 |
| Teva Pharmaceuticals USA, Inc. | 5 | $88 |
Products named: VRAYLAR, REXULTI, HETLIOZ, ARISTADA, Jornay PM, Auvelity, CAPLYTA, Dyanavel XR.
Industry payments across NC — which companies pay providers there.
